Ekopak NV (EKOP) Fair Value & Analysis
Utilities · BE · Market cap €70.9M
Fair value as of: Jun 24, 2026
Analysis
Ekopak NV (EKOP) currently trades at €3.80, while our model-based Fair Value estimate is €4.34 — implying the stock looks roughly 14.2% undervalued today. We read business quality at 95/100 (high quality), in the Utilities sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.
About the company
Ekopak NV engages in designing, building, financing, maintaining, and operating industrial water processing installations in Belgium, the Asia Pacific, Africa, rest of Europe, and the United States. The company operates in two segments, Project Business and Water-As-A-Service (WaaS). It offers maintenance, water analyses, treatment of cooling or boiler water, disinfection, pump services, chemical services, corrosion control, and biogas valorization; water treatment, including rainwater, surface water, and wastewater; wastewater treatment, such as primary treatment, anaerobic treatment, and aerobic treatment solution; REUSE, which converts effluent (treated wastewater) from sewage treatment plants into process water for industrial use; waste-to-energy and biogas valorization, a bio-waste that can be converted into biogas, which is captured and used as fuel; and resins/ion exchangers, as well as offers various biogas burners and flares. The company serves food, pharmaceuticals, chemic…
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Ekopak NV (EKOP) undervalued?
What is the fair value of EKOP?
What is the quality score of EKOP?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.